Quick Nav
Publications
Pharmacy Times
Clinical Trials

New Drug Blocks Out AIDS Virus

Susan Farley
Published Online: Saturday, October 1, 2005   [ Request Print ]

At the recent International Congress on AIDS, Japanese researchers introduced a new HIV drug that blocks out the AIDS virus before it enters human cells. Known as AK602, the drug acts by attaching itself to the protein that serves as the virus' entryway into human cells. Whereas other AIDS medications lose their effectiveness when the virus develops a resistance to them, AK602 acts by addressing the human cells rather than the virus. Clinical trials were conducted on 40 US patients with AIDS who took 0.02 oz of AK602 bid for 10 days. The resulting percentage of HIV viruses dropped to an average of 1%. The researchers noted no reported side effects.

Ms. Farley is a freelance medical writer based in Wakefield, RI.

Related Articles
No Result Found




Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.
 




Become a Member
Forgot Password?